Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Therapeutics, Inc. Lawsuit - NTLA
Portfolio Pulse from
Levi & Korsinsky has announced a lead plaintiff deadline of April 14, 2025, for a lawsuit involving Intellia Therapeutics, Inc. (NASDAQ:NTLA). Shareholders who suffered losses can seek potential recovery under federal securities laws.
March 18, 2025 | 10:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a lawsuit with a lead plaintiff deadline set for April 14, 2025. Shareholders who incurred losses may be eligible for recovery under federal securities laws.
The announcement of a lawsuit and the opportunity for shareholders to seek recovery can create uncertainty and potential negative sentiment around Intellia Therapeutics, likely impacting its stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100